Jonathan Drachman
2021 - Aquinox Pharmaceuticals
In 2021, Jonathan Drachman earned a total compensation of $2.7M as Chief Executive Officer at Aquinox Pharmaceuticals, a 41% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $208,354 |
---|---|
Salary | $438,640 |
Stock Awards | $1,998,837 |
Other | $4,300 |
Total | $2,650,131 |
Drachman received $2M in stock awards, accounting for 75% of the total pay in 2021.
Drachman also received $208.4K in non-equity incentive plan, $438.6K in salary and $4.3K in other compensation.
Rankings
In 2021, Jonathan Drachman's compensation ranked 4,921st out of 12,405 executives tracked by ExecPay. In other words, Drachman earned more than 60.3% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 4,921 | 60th |
Manufacturing | 2,055 | 63rd |
Chemicals And Allied Products | 870 | 63rd |
Drugs | 779 | 63rd |
Pharmaceutical Preparations | 554 | 64th |
Drachman's colleagues
We found two more compensation records of executives who worked with Jonathan Drachman at Aquinox Pharmaceuticals in 2021.